BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11020835)

  • 1. [Roaming through methodology. XXIII. The need for randomization and blinding in therapeutic investigations].
    Knipschild PG
    Ned Tijdschr Geneeskd; 2000 Sep; 144(38):1826-8. PubMed ID: 11020835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Roaming through methodology. XXIII. The need for randomization and blinding in therapeutic investigations].
    Dorhout Mees EJ
    Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2228. PubMed ID: 11103264
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral research and the double-blind placebo-controlled methodology: challenges in applying the biomedical standard to behavioral headache research.
    Rains JC; Penzien DB
    Headache; 2005 May; 45(5):479-86. PubMed ID: 15953264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
    Haahr MT; Hróbjartsson A
    Clin Trials; 2006; 3(4):360-5. PubMed ID: 17060210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies should be controlled, randomized, and blinded.
    Parker RA
    Clin Pharmacol Ther; 2009 May; 85(5):461-3. PubMed ID: 19381148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.
    Hróbjartsson A; Forfang E; Haahr MT; Als-Nielsen B; Brorson S
    Int J Epidemiol; 2007 Jun; 36(3):654-63. PubMed ID: 17440024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective patient blinding during hyperbaric trials.
    Clarke D
    Undersea Hyperb Med; 2009; 36(1):13-7. PubMed ID: 19341123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalence trials: methodologic analysis.
    Carneiro A
    Rev Port Cardiol; 2003 Sep; 22(9):1125-39. PubMed ID: 14655314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method to estimate the variance of an endpoint from an on-going blinded trial.
    Xing B; Ganju J
    Stat Med; 2005 Jun; 24(12):1807-14. PubMed ID: 15803440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-randomization and de-randomization in emergency medical research: new names and rigorous criteria for old methods.
    Hallstrom AP; Paradis NA
    Resuscitation; 2005 Apr; 65(1):65-9. PubMed ID: 15797277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing allocation concealment and blinding in randomized controlled trials: why bother?
    Schulz KF
    ACP J Club; 2000; 132(2):A11-2. PubMed ID: 10750446
    [No Abstract]   [Full Text] [Related]  

  • 13. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods.
    Devereaux PJ; Choi PT; El-Dika S; Bhandari M; Montori VM; Schünemann HJ; Garg AX; Busse JW; Heels-Ansdell D; Ghali WA; Manns BJ; Guyatt GH
    J Clin Epidemiol; 2004 Dec; 57(12):1232-6. PubMed ID: 15617948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The blind leading the blind: use and misuse of blinding in randomized controlled trials.
    Miller LE; Stewart ME
    Contemp Clin Trials; 2011 Mar; 32(2):240-3. PubMed ID: 21070890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.
    Fergusson D; Glass KC; Waring D; Shapiro S
    BMJ; 2004 Feb; 328(7437):432. PubMed ID: 14761905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evidence-based clinical practice].
    Gluud C
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):541-7. PubMed ID: 12905675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in beliefs identify unblinding in randomized controlled trials: a method to meet CONSORT guidelines.
    Rees JR; Wade TJ; Levy DA; Colford JM; Hilton JF
    Contemp Clin Trials; 2005 Feb; 26(1):25-37. PubMed ID: 15837450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The quality of reporting and outcome measures in randomized clinical trials related to upper-extremity disorders.
    Gummesson C; Atroshi I; Ekdahl C
    J Hand Surg Am; 2004 Jul; 29(4):727-34; discussion 735-7. PubMed ID: 15249101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redefining the randomized controlled trial in the context of acupuncture research.
    Walji R; Boon H
    Complement Ther Clin Pract; 2006 May; 12(2):91-6. PubMed ID: 16648085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.